Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma

American Journal of Pathology

Volumn 159, Issue 2, 2001, Pages 425-429

  Suzuki, Ritsuro ^a   Takemura, Kazuo ^b   Tsutsumi, Masayoshi ^b   Nakamura, Shigeo ^a   Hamajima, Nobuyuki ^a   Seto, Masao ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PHOSPHODIESTERASE I;

ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CLINICAL ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MANTLE CELL LYMPHOMA; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034888874     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61713-0     Document Type: Article

References (35)

1. Mantle cell lymphoma - An entity comes of age
2. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma
3. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997
4. Selective usage of D-type cyclins in lymphoid malignancies
5. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma
6. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma
7. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas
8. Molecular diagnostic approach to non-Hodgkin's lymphoma
9. Establishment of a new human B-cell line carrying t(11;14) chromosome abnormality
10. Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies
11. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture
12. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome
13. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation
14. A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony-stimulating factor receptors and macrophage colony-stimulating factor receptors
15. Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells
16. Establishment and characterization of a new human leukemia cell line derived from M4Eo
17. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13
18. HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression
19. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryobiastic leukaemia
20. Human chronic myelogenous leukemia cellline with positive Philadelphia chromosome
21. Establishment and characterization of a human histiocytic lymphoma cell line (U-937)
22. Phenotypic and genotypic lineage switch of a lymphoma with shared chromosome translocation and T-cell receptor gamma gene rearrangement
23. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas
24. CD5-expressing B-cell non-Hodgkin's lymphoma with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis
25. Somatic hypermutation in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas
26. Detection of 11q13 rearrangement in hematologic neoplasias by double-color fluorescence in situ hybridization
27. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas
28. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphoma
29. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease
30. Mantle cell lymphoma: A retrospective study of 121 cases
31. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies
32. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene
33. Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)
34. Real-time 5′→3′ exonuclease-bases PCR assay for detection of the t(11;14)(q13;q32)
35. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukemia